Clinical trial
Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast…
NCT00025688 · Theradex, Industry · Unknown status
Key facts
| NCT number | NCT00025688 |
|---|---|
| Title | Paclitaxel With or Without Carboplatin in Treating Women With Metastatic Breast Cancer |
| Official title | A Randomized, Phase II Trial of Weekly Taxol (Paclitaxel) Versus Weekly Taxol Plus Paraplatin (Carboplatin) as First-Line Chemotherapy in Patients Age 65 Years or Older With Metastatic Breast Cancer |
| Lead sponsor | Theradex, Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | carboplatin, paclitaxel |
| Start date | Jan 1, 2001 |
| First posted | Aug 5, 2003 |
| Last update posted | Jul 24, 2008 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: